Evidence map›Paper›PMID 41454219›Full record

ArticleBMC microbiology2025

Evolutionary genomics of KPC-2-producing Serratia marcescens and characterization of a novel bla

Yali Zheng, Ying Jing, Yan Zhang, Jin Zhang, Jianbo Ye, Huimin Chen, Yuting Jin, Jiayu He, Yu Zhang, Xinhua Luo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yali Zheng *Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Ying Jing *Department of Clinical Laboratory Center, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing, China.
Yan ZhangShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Jin ZhangDepartment of Clinical Laboratory Medicine, School of Medicine, Taizhou Municipal Hospital, Taizhou University Affiliated Municipal Hospquestital), Taizhou University, Taizhou, China.
Jianbo YeDepartment of Clinical Laboratory Medicine, School of Medicine, Taizhou Municipal Hospital, Taizhou University Affiliated Municipal Hospquestital), Taizhou University, Taizhou, China.
Huimin ChenDepartment of Clinical Laboratory Medicine, School of Medicine, Taizhou Municipal Hospital, Taizhou University Affiliated Municipal Hospquestital), Taizhou University, Taizhou, China.
Yuting JinDepartment of Clinical Laboratory Medicine, School of Medicine, Taizhou Municipal Hospital, Taizhou University Affiliated Municipal Hospquestital), Taizhou University, Taizhou, China.
Jiayu HeTaizhou Jiaojiang District Maternal And Child Health Care Hospital, Taizhou, China.
Yu ZhangSchool of Life Sciences, Suzhou Medical College of Soochow University, Suzhou, China.
Xinhua LuoDepartment of Clinical Laboratory Medicine, School of Medicine, Taizhou Municipal Hospital, Taizhou University Affiliated Municipal Hospquestital), Taizhou University, Taizhou, China. luoxiangnanchang84@163.com.

Funding

Medical and Health Science and Technology Project of Zhejiang Province 2024KY543Medical and Health Science and Technology Project of Zhejiang Province 2025KY461Natural Science Foundation of Zhejiang Province LTGY23H190003
6 · The paper itself

Abstract

backgroundSerratia marcescens is a common opportunistic pathogen in hospitals. Its carbapenem-resistant strains, especially those carrying the bla

methodsIn this study, we identified 14 strains that were positive for bla

resultsA total of 121 strains (6.03%) were found to carry bla

conclusionsThis study systematically describes the global transmission patterns and molecular genetic features of Serratia marcescens strains carrying bla

Indexed as

Bacterial Proteinsbeta-LactamasesPlasmidsSerratia marcescensAnti-Bacterial AgentsChinaDrug Resistance, Multiple, BacterialEvolution, MolecularGenomicsHumansMicrobial Sensitivity TestsPhylogenySerratia InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase KPC-2beta-LactamasesAntimicrobial resistanceCarbapenem-resistant strainsNovel plasmidPhylogenetic analysisSerratia marcescensUnit transposon ΔTn6296

Identifiers

PMID41454219
PMCPMC12869953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.